Insider Trading disclosures for Deep Medicine Acquisition Corp - Ordinary Shares - Class A
The latest disclosure was made by Humphrey P. Polanen in Deep Medicine Acquisition Corp - Ordinary Shares - Class A where a trade of 25,000
Class B Common Stock done
was reported to US exchanges on April 27, 2022.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Humphrey P. Polanen
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
27 Apr 2022 |
25,000 |
25,000
|
-
|
|
-
|
Class B Common Stock |
|
Ronald M. Razmi
|
Director |
Other type of transaction at price $ 0.00 per share. |
27 Apr 2022 |
50,000 |
50,000
|
-
|
|
-
|
Class B Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges